CRIS Current Research Information System

GIANNI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.365
NA - Nord America 377
EU - Europa 265
SA - Sud America 46
AF - Africa 39
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.097
Salva come PNG Salva come JPEG
Nazione #
VN - Vietnam 560
US - Stati Uniti d'America 364
SG - Singapore 258
CN - Cina 230
HK - Hong Kong 133
IT - Italia 85
KR - Corea 58
FR - Francia 37
IN - India 28
DE - Germania 25
NL - Olanda 23
BR - Brasile 22
JP - Giappone 20
FI - Finlandia 19
TH - Thailandia 14
CI - Costa d'Avorio 13
PH - Filippine 13
SE - Svezia 13
IE - Irlanda 11
BD - Bangladesh 10
GB - Regno Unito 10
SC - Seychelles 9
AT - Austria 8
RU - Federazione Russa 8
AR - Argentina 7
CA - Canada 7
ID - Indonesia 7
GH - Ghana 6
JO - Giordania 5
CH - Svizzera 4
CL - Cile 4
LT - Lituania 4
TW - Taiwan 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
ES - Italia 3
IQ - Iraq 3
MX - Messico 3
PK - Pakistan 3
RO - Romania 3
TG - Togo 3
ZA - Sudafrica 3
CO - Colombia 2
EC - Ecuador 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
OM - Oman 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
MA - Marocco 1
MG - Madagascar 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.097
Salva come PNG Salva come JPEG
Città #
Singapore 196
Ho Chi Minh City 149
Hanoi 135
Hong Kong 122
San Jose 114
Hefei 99
Ashburn 49
Seoul 49
Council Bluffs 35
Los Angeles 29
Bologna 22
Santa Clara 22
Da Nang 21
Lauterbourg 21
Haiphong 17
Abidjan 13
Tokyo 13
Dublin 11
Ha Long 10
Helsinki 10
Hải Dương 10
Beijing 9
Bengaluru 9
Lappeenranta 9
Thái Nguyên 9
Amsterdam 8
Biên Hòa 8
Bắc Giang 8
Boardman 7
Frankfurt am Main 7
Accra 6
Bangkok 6
Princeton 6
Can Tho 5
Chandler 5
Des Moines 5
Hangzhou 5
Jakarta 5
Milan 5
Modena 5
Quận Bình Thạnh 5
Thái Bình 5
Vienna 5
Điện Bàn 5
Amman 4
New York 4
Quận Phú Nhuận 4
Ravenna 4
Rome 4
Southend 4
Vũng Tàu 4
Baghdad 3
Buffalo 3
Bắc Ninh 3
Caracas 3
Dallas 3
Delhi 3
Guangzhou 3
Hyderabad 3
La Paz 3
Lomé 3
Long Xuyen 3
Montreal 3
Monzuno 3
Munich 3
Nha Trang 3
Ninh Bình 3
Nuremberg 3
Paris 3
Phủ Lý 3
Quận Sáu 3
San Diego 3
Shanghai 3
Sofia 3
São Paulo 3
Vinh 3
Zurich 3
Almaty 2
Bucharest 2
Bình Phước 2
Bạc Liêu 2
Chennai 2
Chicago 2
Fairfield 2
Gaziantep 2
Genoa 2
Guayaquil 2
Huế 2
Jeonju 2
Johannesburg 2
Joinville 2
Ludhiana 2
Moscow 2
Muscat 2
Pristina 2
Quezon City 2
Quảng Ngãi 2
Quận Một 2
Redondo Beach 2
Reggio Emilia 2
Totale 1.446
Salva come PNG Salva come JPEG
Nome #
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants 348
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 164
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 151
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 150
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 143
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 130
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 94
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 86
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 82
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial 76
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors 72
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 54
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer 52
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer 51
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 47
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 45
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 36
Circulating tumor DNA detection of local recurrence in a patient with early stage triple-negative breast cancer 30
Mapping breast cancer therapy with circulating tumor cells: The expert perspective 30
Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-institutional study 29
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 28
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study 26
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors 24
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 24
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer 23
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis 22
Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report 22
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer 21
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer 21
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 18
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all? 16
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine 14
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review 13
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates 12
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma 10
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors 8
Totale 2.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 3 1 1 5 2 0 7 13 7
2022/202341 3 5 1 4 4 2 3 1 10 1 2 5
2023/202442 2 3 0 0 2 5 7 5 8 9 0 1
2024/2025273 17 22 24 24 24 15 7 12 9 21 30 68
2025/20261.777 309 114 79 68 61 22 318 112 513 181 0 0
Totale 2.172